Patent · US Active

Variable lymphocyte receptors that target the brain extracellular matrix and methods of use

US12077609B2 · kind B2 · utility

0Cited by
4References
30Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 19, 2019
Grant dateSep 3, 2024
Priority date
Expiry dateAug 22, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides isolated polypeptides comprising variable lymphocyte receptors that specifically bind the brain extracellular matrix, compositions, and methods of use. Methods of using the variable lymphocyte receptors for the detection and treatment of disease or injury, specifically, for example, cancers including glioblastoma are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.